Perceived Burden of Completion of Patient-Reported Outcome Measures in Clinical Trials:: Results of a Preliminary Study

被引:16
|
作者
Bodart, Serge [1 ]
Byrom, Bill [2 ]
Crescioni, Mabel [3 ]
Eremenco, Sonya [3 ]
Flood, Emuella [4 ]
机构
[1] Bracket Global, Montreal, PQ, Canada
[2] CRF Hlth, Brook House,3rd Floor,229-243 Shepherds Bush Rd, London, Greater London, England
[3] Crit Path Inst, Tucson, AZ USA
[4] ICON Clin Res, Gaithersburg, MD USA
关键词
subject burden; patient-reported outcome; patient-reported outcome measure; PRO; PROMs;
D O I
10.1177/2168479018788053
中图分类号
R-058 [];
学科分类号
摘要
Background: Understanding the perceived burden of clinical trial participation is an important element of patient-centric trial design and conduct. Methods: We report the results of a study to gain preliminary insights into the perceived burden associated with patient-reported outcome (PRO) data collection among a sample (n = 61) of volunteers from the general population including people with various health conditions resulting in chronic pain. Results: Participants identified morning completion as more burdensome than completion of PRO measures in the evening. Weekly completion was perceived as less burdensome than daily, and twice-a-day more burdensome than once-a-day. Conclusion: Our results, while not generalizable in isolation, provide a valuable starting point to understand the complex construct of subject burden. This preliminary work is intended to be a catalyst for more in-depth research to better understand and predict burden and acceptable burden thresholds in clinical trials. Understanding subject burden is a vital component of human subject research that will be valuable in helping to inform future clinical trial designs.
引用
收藏
页码:318 / 323
页数:6
相关论文
共 50 条
  • [31] Respondent Burden and Readability of Patient-Reported Outcome Measures for People With Aphasia
    Engelhoven, Amy E. R.
    Bislick, Lauren
    Gray, Sara
    Pompon, Rebecca Hunting
    TOPICS IN LANGUAGE DISORDERS, 2022, 42 (03) : 266 - 282
  • [32] Gaucher disease (GD)-specific patient-reported outcome (PRO) measures for clinical monitoring and for clinical trials
    Elstein, Deborah
    Klemen, Martin
    Panter, Charlotte
    Bonner, Nicola
    Johnson, Chloe
    Zimran, Ari
    MOLECULAR GENETICS AND METABOLISM, 2019, 126 (02) : S52 - S52
  • [33] Patient-Reported Physical Function Measures in Cancer Clinical Trials
    Atkinson, Thomas M.
    Stover, Angela M.
    Storfer, Daniel F.
    Saracino, Rebecca M.
    D'Agostino, Thomas A.
    Pergolizzi, Denise
    Matsoukas, Konstantina
    Li, Yuelin
    Basch, Ethan
    EPIDEMIOLOGIC REVIEWS, 2017, 39 (01) : 59 - 70
  • [34] Radiochemotherapy and interstitial brachytherapy for cervical cancer: clinical results and patient-reported outcome measures
    Alfrink, Johanna
    Aigner, Thomas
    Zoche, Hermann
    Distel, Luitpold
    Grabenbauer, Gerhard G.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2024, 200 (08) : 706 - 714
  • [35] Patient-reported Outcome Measures in Systemic Lupus Erythematosus: Use in Clinical Practice - Preliminary Results from the Integrate Project
    Chehab, Gamal
    Richter, Jutta
    Kernder, Anna
    Tani, Chiara
    Lorenzoni, Valentina
    Elefante, Elena
    Palla, Ilaria
    Cannizzo, Sara
    Pirri, Salvatore
    Triulzi, Isotta
    Trieste, Leopoldo
    Turchetti, Giuseppe
    Mosca, Marta
    Schneider, Matthias
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [36] Interpreting the results of patient reported outcome measures in clinical trials:: The clinician's perspective
    Schuenemann, Holger J.
    Akl, Elie A.
    Guyatt, Gordon H.
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2006, 4 (1)
  • [37] It is time for an organised, scientific approach to the application of patient-reported outcome measures in clinical studies and trials
    McKenna, Stephen P.
    CLINICAL RHEUMATOLOGY, 2019, 38 (02) : 611 - 615
  • [38] Non-English language validation of patient-reported outcome measures in cancer clinical trials
    Stephen R. Grant
    Sonal S. Noticewala
    Walker Mainwaring
    Timothy A. Lin
    Austin B. Miller
    Amit Jethanandani
    Andres F. Espinoza
    G. Brandon Gunn
    C. David Fuller
    Charles R. Thomas Jr
    Lorraine Portelance
    Ethan B. Ludmir
    Supportive Care in Cancer, 2020, 28 : 2503 - 2505
  • [39] Non-English language validation of patient-reported outcome measures in cancer clinical trials
    Grant, Stephen R.
    Noticewala, Sonal S.
    Mainwaring, Walker
    Lin, Timothy A.
    Miller, Austin B.
    Jethanandani, Amit
    Espinoza, Andres F.
    Gunn, G. Brandon
    Fuller, C. David
    Charles, R. Thomas, Jr.
    Portelance, Lorraine
    Ludmir, Ethan B.
    SUPPORTIVE CARE IN CANCER, 2020, 28 (06) : 2503 - 2505
  • [40] PATIENT-REPORTED OUTCOME MEASURES FOR MULTIPLE SCLEROSIS PHASE IV CLINICAL TRIALS: A SYSTEMATIC REVIEW
    Ting, J.
    Zhong, L.
    Petrillo, J.
    Niu, C.
    Lee, A.
    Sarda, S.
    VALUE IN HEALTH, 2015, 18 (03) : A286 - A286